Collections

Business on the Front Lines

News and perspectives from corporations working to directly impact the COVID-19 public health crisis. Content from this collection may include updates from medical supply or pharmaceutical companies, businesses that have pivoted their production to support the medical response to COVID-19 or hospitals that are navigating many secondary impacts of the pandemic (both economic and human).

Moderna loses challenge to Arbutus patent on vaccine technology

Moderna loses challenge to Arbutus patent on vaccine technology

By: Jan Wolfe
Source: Reuters
Date of Publication: July 23rd, 2020
Shares of Moderna Inc fell nearly 10% after it lost a bid to invalidate a U.S. patent owned by Arbutus Biopharma that poses a potential obstacle to Moderna’s efforts to develop next-generation vaccines, including a coronavirus vaccine.
Oxford University's coronavirus vaccine with AstraZeneca shows positive immune response in early trial

Coronavirus vaccine from Oxford and AstraZeneca shows positive response in early trial

By: Berkeley Lovelace Jr. and Lucy Handley
Source: CNBC
Date of Publication: July 20th, 2020
A potential coronavirus vaccine developed by Oxford University in the U.K. with pharmaceutical giant AstraZeneca has produced a promising immune response in a large, early-stage human trial.
Surging demand for medical equipment puts Philips on course for second-half recovery

Surging demand for medical equipment puts Philips on course for second-half recovery

By: Bart H. Meijer
Source: Reuters
Date of Publication: July 20th, 2020
Electrical equipment maker Philips said a recent surge in orders for scanners and other medical equipment should enable group sales and margins to rebound over the next six months from a slump in the second quarter.
N95 Face Mask Makers Ramp Up Production to Meet U.S. Covid-19 Demand - WSJ

N95 Face Mask Makers Ramp Up Production to Meet U.S. Covid-19 Demand

By: Austen Hufford
Source: The Wall Street Journal
Date of Publication: July 17th, 2020
American companies like 3M, Honeywell and Prestige Ameritech are investing in domestic production of masks.
CVS Covid-19 Test Results Are Taking Longer Than Customers Have Been Told - WSJ

CVS Covid-19 Test Results Are Taking Longer Than Customers Have Been Told

By: Scott Patterson, Sarah Krouse and Sharon Terlep
Source: The Wall Street Journal
Date of Publication: July 17th, 2020
Testees complain about waiting more than 10 days as coronavirus cases surge in U.S.
Demand For Abbott Labs Covid-19 Tests Surges Past 40 Million As Pandemic Cases Surge_Forbes

Demand For Abbott Labs Covid-19 Tests Surges Past 40 Million As Pandemic Cases Surge

By: Bruce Japsen
Source: Forbes
Date of Publication: July 16th, 2020
Abbott Laboratories said demand is surging for its portfolio of tests for the coronavirus strain Covid-19 as the pandemic triggers unprecedented need for its diagnostic products around the world.
Moderna spars with US scientists over COVID-19 vaccine trials

Exclusive: Moderna spars with U.S. scientists over COVID-19 vaccine trials

By: Marisa Taylor and Robin Respaut
Source: Reuters
Date of Publication: July 7th, 2020
As the United States accelerates the search for a coronavirus vaccine, tensions have erupted between government scientists and Moderna Inc, one of the leading developers, Reuters has learned.
U.S. government awards Novavax $1.6 billion for coronavirus vaccine

U.S. government awards Novavax $1.6 billion for coronavirus vaccine

By: Julie Steenhuysen
Source: Reuters
Date of Publication: July 7th, 2020
The U.S. government has awarded Novavax Inc $1.6 billion to cover testing, commercialization and manufacturing of a potential coronavirus vaccine in the United States, with the aim of delivering 100 million doses by January 2021.
COVID-19 — a timeline of the coronavirus outbreak

COVID-19 — a timeline of the coronavirus outbreak

By: Jenny Lei Ravelo, Sara Jerving
Source: Devex
Date of Publication: July 3rd, 2020
The timeline below tracks the development of the outbreak as it unfolds. Total cases as of July 3: 10,871,362 and 521,298 deaths.
Pfizer reports encouraging early covid-19 vaccine data

Pfizer reports encouraging early coronavirus vaccine data

By: Carolyn Y. Johnson
Source: The Washington Post
Date of Publication: July 1st, 2020
In a small trial, an experimental vaccine triggered immune responses similar to those in recovered patients.

Browse Collections

  • The Changing Nature of Work COVID-19

    The Changing Nature of Work

    From virtual offices to essential workers, explore how companies are adapting to changes in the way we work.
    Read More
  • Business on the Front Lines COVID-19

    Business on the Front Lines

    News and perspectives from corporations rising to the challenge of the COVID-19 public health crisis.
    Read More
  • Leading in a Crisis COVID-19.

    Leading in a Crisis

    Uncertainty can be disorienting and disruptive. Learn from business leaders about what it’s like to navigate their organizations and people through a global pandemic.
    Read More
  • Service and Community COVID-19

    Service and Community

    We’re in this together. Discover ways corporations are serving their communities and pivoting to become essential services.
    Read More